ALZN Chart
See on advanced chart >
About
Alzamend Neuro, Inc. was incorporated on February 26, 2016 under the laws of the State of Delaware. The company is a clinical-stage biopharmaceutical company focused on developing novel products for the treatment of Alzheimer's disease, bipolar disorder,...
Read More
- HighlightAn early clinical-stage biopharmaceutical company that developing novel products for the Alzheimer's disease, bipolar disorder, major depressive disorder and post-traumatic stress disorder
- ExchangeNASDAQ
- Listing Date06/15/2021
- Established Date02/26/2016
- Full-time Employees4
- Address3480 Peachtree Road NE Second Floor Suite 103 Atlanta GA 30326
- Tel1-844-7226333
- Website
- Fiscal Year End Date04/30
- Security TypeCommon Stock
Industry
Pharmaceuticals